What Can We Expect From Xeris Pharmaceuticals (XERS) After Jefferies’s Latest Coverage?

July 16, 2018 - By Vernon Prom

Why Has Jefferies Given Xeris Pharmaceuticals (XERS) a $23.0 Price Target

Analysts at Jefferies has initiated coverage on shares of Xeris Pharmaceuticals (XERS) in a report released on 16 July. The company set “Buy” rating on the $378.87 million market cap company.

The stock decreased 0.54% or $0.1 during the last trading session, reaching $18.4. About 32,485 shares traded. Xeris Pharmaceuticals, Inc. (XERS) has 0.00% since July 16, 2017 and is . It has underperformed by 12.57% the S&P500.

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes ready-to-use injectable and infusible drug formulations. The company has market cap of $378.87 million. The Company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of highly-concentrated, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using commercially available syringes, auto-injectors, multi-dose pens, and infusion pumps. It currently has negative earnings. The company's lead product candidate is glucagon rescue pen, which has completed Phase III clinical trials for the treatment of severe hypoglycemia, a potentially life-threatening condition in people with diabetes.

More notable recent Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) news were published by: Benzinga.com which released: “Benzinga’s Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street” on June 21, 2018, also Benzinga.com with their article: “56 Biggest Movers From Yesterday” published on June 22, 2018, Seekingalpha.com published: “Premarket analyst action – healthcare” on July 16, 2018. More interesting news about Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) were released by: Streetinsider.com and their article: “UPDATE: RBC Capital Starts Xeris Pharmaceuticals (XERS) at Outperform” published on July 16, 2018 as well as Nasdaq.com‘s news article titled: “Nasdaq’s Hot First Day of Summer – Six IPOs Join our Market” with publication date: June 22, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.